fbpx

Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

Multiple Myeloma- Complementary, Integrative Tx

Share Button

Conventional Oncology Does Not Cure Multiple Myeloma- Understand Complementary and Integrative Therapies to Give you Choices…

The good news is that there is a long and growing list of FDA approved chemotherapy regimens for the treatment of multiple myeloma (MM). The bad news is that they are expensive,  toxic and do not cure multiple myeloma.

Consider evidence-based complementary and integrative therapies.

I was diagnosed with multiple myeloma in 2/94, underwent 3 years of conventional therapies including an autologous stem cell transplant in 12/95 and was told that nothing more could be done for me in 9/97. I researched and developed an evidence-based, non-toxic, anti-MM lifestyle through nutrition, supplementation, bone health, lifestyle and mind-body therapies based on the pathways linked below.

I am a long-term MM survivor and MM cancer coach. Complementary and Integrative Therapies are discussed in the MM Cancer Coaching Guide called Non-Conventional Therapies. The therapies that I have personal experience with are:

The CAM therapies for multiple myeloma above provide a host of benefits beyond killing cancer. Detoxification, heart health, brain health, nerve and muscle health is provided by these therapies.

While I consider conventional, FDA approved, therapies for multiple myeloma to be the mainstay of care I also think that myeloma is a complicated blood cancer that requires a multi-pronged therapy plan. Complementary and Integrative therapies can provide the needed multi-pronged approach.

Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.

 

David Emerson

  • MM Survivor,
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity

Background: Despite the advances in the treatment of multiple myeloma (MM), complete remission is usually challenging. The interactions between tumor and host cells, in which exosomes (EXs) play critical roles, have been shown to be among the major deteriorative tumor-promoting factors herein. Therefore, any endeavor to beneficially target these EX-mediated interactions could be of high importance…

Results: Myeloma EXs (C-EXs) significantly reduced NK cytotoxicity against K562 cells (P ≤ 0.05), while the cytotoxicity suppression was significantly lower (P ≤ 0.05) in the (E-EX)- and (D-EX)-treated NK cells compared to the (C-EX)-treated cells. The expression of the activating NK receptor NKG2D and NK degranulation, after treatment with the EXs, were both altered following the same pattern. However, C-EXs could increase IFN-γ production in NK cells (P < 0.01), which was not significantly affected by EPA/DHA treatment. This indicates a dual effect of myeloma EXs on NK cells functions.

Conclusion: Our observations showed that myeloma EXs have both suppressive and stimulatory effects on different NK functions. Treatment of myeloma cells with EPA/DHA can reduce the suppressive effects of myeloma EXs while maintaining their stimulatory effects. These findings, together with the previous findings on the anti-cancer effects of EPA/DHA, provide stronger evidence for the repositioning of the currently existing EPA/DHA supplements to be used in the treatment of MM as an adjuvant treatment. EXs released from L363 (myeloma) cells in their steady state increase IFN-γ production of NK cells, while reduce their cytotoxicity against the K562 cell line (right blue trace). EXs from L363 cells pre-treated with either EPA or DHA are weaker stimulators of IFN-γ production. These EXs also increase NK cytotoxicity and NKG2D expression (left brown trace) compared to the EXs obtained from untreated L363 cells. Based on these findings, myeloma EXs have both suppressive and stimulatory effects on different NK functions depending on the properties of their cells of origin, which can be exploited in the treatment of myeloma…”

The Most BioAvailable Curcumin Formulas

“Based on a review of these studies, it is evident that better bioavailability of formulated curcumin (CU) products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism”

A search of the Pubmed database for the word curcumin yields 601 studies spaning health topics from multiple myeloma and colorectal cancer, to chemotherapies that synergizes with CU, to Alzheimer’s Disease, arthritis and more. Based on years of reading studies and personal accounts, I think it is safe to say that CU supplementation is safe and relatively inexpensive.

I have read about myeloma patients taking daily doses of CU from 400 milligrams to 8 grams (1000 milligrams = 1 gram). By almost any measure, CU is a safe, inexpensive wonder drug.

The only challenge is that CU is famously difficult to absorb in the body. In other words, a person has to mix curcumin with some sort of fat (coconut oil, chocolate, etc.) or take a brand of curcumin capsule that is already formulated to be more “bioavailable” in order to derive the full benefit of CU.

The study linked and exerpted below reviews different formulations of CU. The study itself lists the three most bioavailable formulation/brand of CU and I’ve added an excerpt from a further review from Consumerlab.com that lists four additional bioavailable brands of CU.


Recommended Reading:


Curcumin

CU is a bright yellow chemical produced by some plants. It is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, Zingiberaceae. It is sold as an herbal supplement, cosmetics ingredient, food flavoring, and food coloring.[1]

Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers.

“Curcumin is a widely studied natural compound which has shown tremendous in vitro therapeutic potential. Despite that, the clinical efficacy of the native CU is weak due to its low bioavailability and high metabolism in the gastrointestinal tract. During the last decade, researchers have come up with different formulations with a focus on improving the bioavailability of curcumin. As a result, a significant number of bioavailable curcumin-based formulations were introduced with the varying range of enhanced bioavailability.

The purpose of this review is to collate the published clinical studies of CU products with improved bioavailability over conventional (unformulated) CU. Based on the literature search, 11 curcumin formulations with available human bioavailability and pharmacokinetics data were included in this review. Further, the data on clinical study design, analytical method, pharmacokinetic parameters and other relevant details of each formulation were extracted.

Based on a review of these studies, it is evident that better bioavailability of formulated curcumin products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism. The review hopes to provide a quick reference guide for anyone looking information on these bioavailable curcumin formulations.

Based on the published reports,

exhibited over 100-fold higher bioavailability relative to reference unformulated CU. Suggested mechanisms accounting for improved bioavailability of the formulations and details on the bioanalysis methods are also discussed.”

According to Consumerlab.com:

“Novasol has the highest bioavailability (185 x compared to unforumulated CU), followed by Curcuwin (136 x), Longvida (100 x), Meriva (48 x), BCM-95 (27 x), Curcumin C3 Complex + Bioperene (20 x), and then Theracumin (16 x).”

Leave a Comment:

9 comments
Kathryn L Guillaum says a few months ago

The Curcumin I take has bioavailability ingredients but I still take a Tablespoon of Coconut oil with the pill I take. I’m wondering if bodyweight has anything to do with how many capsules I should take? I take Life Extension brand.

Reply
    David Emerson says a few months ago

    Hey Kat- the short answer is that I have an answer about body weight. I would guess so but no way to verify it. For the record, chemotherapy is administered per square inches of body, I think.

    I believe coconut oil is nutritious for several reasons. High in calories but if you don’t have a weight problem you should be fine.

    Reply
Can Velcade/Bortezomib ReChallenge Multiple Myeloma? - PeopleBeatingCancer says a few months ago

[…] Multiple Myeloma- Complementary and Integrative Therapies Multiple Myeloma Signs, Symptoms and Side Effects Omega-3 fatty acids- Kill Myeloma Enhance Chemotherapy […]

Reply
Multiple Myeloma Treatment Guidelines- End-stage or Cure? - PeopleBeatingCancer says a couple of years ago

[…] E-medicine’s Multiple Myeloma guidelines say nothing about evidence-based integrative or complementary therapies. […]

Reply
Multiple Myeloma Treatment Side Effects says a couple of years ago

[…] Multiple Myeloma- Complementary and Integrative Therapies […]

Reply
Multiple Myeloma Pain says a couple of years ago

[…] Multiple Myeloma- Complementary and Integrative Therapies […]

Reply
Chemotherapy Causes Relapse in Multiple Myeloma? - PeopleBeatingCancer says 3 years ago

[…] Multiple Myeloma- Complementary and Integrative Therapies Multiple Myeloma Signs, Symptoms and Side Effects Omega-3 fatty acids- Kill Myeloma Enhance Chemotherapy […]

Reply
Traci Goudie says 5 years ago

WOW! your story and your dedication to finding alternative therapies is incredibly inspiring. Where are you located? I co own a production company in Austin, Texas. We are currently shooting a series of videos on Multiple Myeloma and survivors. We are specifically looking for a person to interview on camera about their journey. Please contact me at your earliest convenience.

Reply
    David Emerson says 5 years ago

    Hi Traci-

    The Galen Foundation DBA PeopleBeatingCancer is a virtual 501c3 non-profit. I should be clear with you. I researched non-conventional MM therapies because the standard-of-care conventional therapies stopped working.

    What is the purpose of the videos about MM? What would you like to know?

    thanks

    David Emerson

    Reply
Add Your Reply